CHAC2 p.Arg174Cys
c.520C>T · VCV4653170
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1464 | likely benign |
|---|---|---|
| REVEL | 0.188 | benign-leaning |
| SaProt | LLR -10.86 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense and REVEL do not. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | GERP 2.9, phastCons 1 |
| Regional constraint | o/e 1.21 | unconstrained · MANE · 6,635 bp · p 0.0017 · regional, not allelic |
| Overall | ||
| CADD | 28.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.00608% | 16,444 |
| European (non-Finnish) | 0.000258% | 387,690 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CHAC2
- Protein
- p.Arg174Cys
- Coding
- c.520C>T
- MANE Select
- NM_016115 · reported on NM_001008708
- Type
- single nucleotide variant
- Location
- chr2:53774490 (GRCh38)
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/chac2-p-arg174cys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown